Video Experimental Relacionado
Updated: Jan 24, 2026
13:47
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10.3K
Entrega de anticuerpos terapéuticos: herramientas vectoriales para aumentar la eficacia y la asequibilidad
Abhishek Chiyyeadu1,2, Bushra Khan1, Katrin Ehrhardt1,2
1Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Frontiers in immunology
|January 23, 2026
Resumen
Las plataformas de terapia génica como el ARNm y los vectores virales ofrecen una alternativa prometedora a la producción tradicional de anticuerpos. Estos métodos avanzados pueden mejorar la expresión in vivo, reduciendo los costos y mejorando el acceso de los pacientes a los anticuerpos terapéuticos.
Área de la Ciencia:
- Biotecnología y Terapia Génica
- Ingeniería de Proteínas y Terapéutica
Sus antecedentes:
- Los anticuerpos (Ab) terapéuticos son vitales pero enfrentan desafíos en la producción y purificación a gran escala, lo que limita el acceso de los pacientes.
- Los avances en bioingeniería han creado moléculas de anticuerpos de próxima generación con capacidades mejoradas.
- Las plataformas de entrega de genes han madurado, ofreciendo soluciones potenciales para la producción de proteínas terapéuticas.
Objetivo del estudio:
- Evaluar críticamente las plataformas de terapia génica para mejorar la expresión in vivo de anticuerpos terapéuticos.
- Discutir estrategias para mejorar la disponibilidad y eficacia in situ de proteínas terapéuticas.
- Explorar avances tecnológicos, desafíos traslacionales y direcciones futuras en terapia génica para la entrega de anticuerpos.
Principales métodos:
- Revisión de plataformas de terapia génica establecidas y emergentes (ARNm, vectores virales, terapias celulares diseñadas).
- Análisis de éxitos clínicos y panorama regulatorio de las tecnologías de entrega de genes.
- Evaluación de sistemas de expresión transitoria vs. estable para la disponibilidad de proteínas in situ.
Principales resultados:
- Las plataformas de terapia génica demuestran un potencial significativo para transformar la entrega de anticuerpos terapéuticos.
- La expresión in vivo a través de la terapia génica puede reducir las cargas de fabricación, mejorar la seguridad y aumentar la tolerabilidad.
- Las aplicaciones clínicas exitosas de vacunas de ARNm, vectores AAV, vectores lentivirales y terapias de células CAR-T subrayan la madurez de la plataforma.
Conclusiones:
- El aprovechamiento de las plataformas de terapia génica puede ampliar el acceso a los anticuerpos terapéuticos al mejorar la expresión in vivo.
- La expresión in situ ofrece beneficios para moléculas similares a anticuerpos diseñadas, superando potencialmente los desafíos de producción y purificación.
- La optimización de los enfoques de terapia génica es crucial para desarrollar intervenciones clínicas ampliamente aplicables para anticuerpos terapéuticos.
Palabras clave:
vectores AAVentrega de anticuerposenfermedades infecciosasvectores lentiviralesARNm-LNPterapia de células plasmáticasMás Videos Relacionados
Videos de Conceptos Relacionados
01:29Self-Efficacy
210
Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
210
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
01:10Antibody Structure
65.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K
01:22Scalar and Vectors
2.1K
In mechanics, commonly used terms like force, speed, velocity, and work can be classified as either scalar or vector quantities. A scalar is a physical quantity that can be described by its magnitude alone and does not require any directional components. Examples of scalar quantities are mass, area, and length.
Scalar quantities with the same physical units can be added or subtracted according to the usual algebra rules for numbers. For example, a class ending 10 min earlier than 50 min lasts...
Scalar quantities with the same physical units can be added or subtracted according to the usual algebra rules for numbers. For example, a class ending 10 min earlier than 50 min lasts...
2.1K
01:30Acceleration Vectors
21.8K
In everyday conversation, accelerating means speeding up. Acceleration is a vector in the same direction as the change in velocity, Δv, therefore the greater the acceleration, the greater the change in velocity over a given time. Since velocity is a vector, it can change in magnitude, direction, or both. Thus acceleration is a change in speed or direction, or both. For example, if a runner traveling at 10 km/h due east slows to a stop, reverses direction, and continues their run at 10 km/h...
21.8K
01:20Vector Operations
2.1K
Vectors are physical quantities that have both magnitude and direction. The vector operations include addition, subtraction, and scalar multiplication.
A vector multiplied by a scalar value is called scalar multiplication. The result obtained is a new vector with a different magnitude. If the scalar is positive, the direction of the vector remains the same, but if it is negative, the direction of the vector is reversed. For example, the product of the mass and velocity yields the momentum.
A vector multiplied by a scalar value is called scalar multiplication. The result obtained is a new vector with a different magnitude. If the scalar is positive, the direction of the vector remains the same, but if it is negative, the direction of the vector is reversed. For example, the product of the mass and velocity yields the momentum.
2.1K